Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]
- PMID: 15574684
- DOI: 10.1124/jpet.104.076901
Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]
Abstract
This study examines the action of the beta(3)-adrenoceptor antagonist SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanoloxalate] at cloned mouse beta(3)-adrenoceptors expressed in Chinese hamster ovary cells (CHO-K1-beta(3)) or endogenously expressed in 3T3-F442A adipocytes or ileum. SR59230A displayed partial agonist properties compared with the beta(3)-adrenoceptor agonist CL316243 [(R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]-propyl]1,3-benzodioxole-2,2-dicarboxylate] in CHO-K1-beta(3) with the intrinsic activity increasing with the level of receptor expression. Functional affinity values for SR59230A at each level of receptor expression were in agreement with pK(I) values determined by binding. In cytosensor microphysiometer studies, SR59230A was a full agonist for increases in extracellular acidification rates (ECARs) at all levels of receptor expression, and antagonist actions were measurable only in medium- or low-expressing cells. In 3T3-F442A adipocytes, SR59230A antagonized CL316243-mediated increases of cAMP and had no agonist actions. However, in the cytosensor micro-physiometer, SR59230A (acting via beta(3)-adrenoceptors) was an agonist with an intrinsic activity greater than CL316243. In mouse ileum, SR59230A relaxed smooth muscle, although concentration-response curves were biphasic. Relaxant effects were produced by concentrations that did not affect cAMP levels. Differences in tissue responses to SR59230A were not caused by major differences in expression of Galphas. ECAR responses were not affected by pretreatment of cells with pertussis toxin, indicating that signaling did not involve Gi. Therefore, SR59230A displays agonist and antagonist actions at the mouse beta(3)-adrenoceptor. Because SR59230A only antagonized accumulation of cAMP in 3T3-F442A adipocytes yet in the same cells was an agonist for ECAR, cAMP-independent signaling pathways must mediate part of the agonist actions in the microphysiometer.
Similar articles
-
Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists.Mol Pharmacol. 2007 Nov;72(5):1359-68. doi: 10.1124/mol.107.035337. Epub 2007 Aug 23. Mol Pharmacol. 2007. PMID: 17717109
-
Functional domains of the mouse beta3-adrenoceptor associated with differential G protein coupling.J Pharmacol Exp Ther. 2005 Dec;315(3):1354-61. doi: 10.1124/jpet.105.091736. Epub 2005 Sep 6. J Pharmacol Exp Ther. 2005. PMID: 16144970
-
beta(3)-adrenoceptor regulation and relaxation responses in mouse ileum.Br J Pharmacol. 2000 Mar;129(6):1251-9. doi: 10.1038/sj.bjp.0703160. Br J Pharmacol. 2000. PMID: 10725275 Free PMC article.
-
Tools to study beta3-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb;374(5-6):385-98. doi: 10.1007/s00210-006-0127-5. Epub 2007 Jan 9. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17211601 Review.
-
The odd sibling: features of β3-adrenoceptor pharmacology.Mol Pharmacol. 2014 Nov;86(5):479-84. doi: 10.1124/mol.114.092817. Epub 2014 Jun 2. Mol Pharmacol. 2014. PMID: 24890609 Review.
Cited by
-
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates.Trends Pharmacol Sci. 2007 Aug;28(8):374-81. doi: 10.1016/j.tips.2007.06.011. Epub 2007 Jul 13. Trends Pharmacol Sci. 2007. PMID: 17629959 Free PMC article. Review.
-
A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.PLoS One. 2010 Nov 30;5(11):e15487. doi: 10.1371/journal.pone.0015487. PLoS One. 2010. PMID: 21152092 Free PMC article.
-
Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value.Acta Physiol (Oxf). 2018 Feb;222(2):e12978. doi: 10.1111/apha.12978. Epub 2017 Oct 30. Acta Physiol (Oxf). 2018. PMID: 28994249 Free PMC article. Review.
-
Desensitization of cAMP Accumulation via Human β3-Adrenoceptors Expressed in Human Embryonic Kidney Cells by Full, Partial, and Biased Agonists.Front Pharmacol. 2019 Jun 7;10:596. doi: 10.3389/fphar.2019.00596. eCollection 2019. Front Pharmacol. 2019. PMID: 31263412 Free PMC article.
-
Factors influencing biased agonism in recombinant cells expressing the human α1A -adrenoceptor.Br J Pharmacol. 2017 Jul;174(14):2318-2333. doi: 10.1111/bph.13837. Epub 2017 Jun 10. Br J Pharmacol. 2017. PMID: 28444738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources